These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 8497058

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Induction of HIV-specific CTL and antibody responses in mice using retroviral vector-transduced cells.
    Warner JF, Anderson CG, Laube L, Jolly DJ, Townsend K, Chada S, St Louis D.
    AIDS Res Hum Retroviruses; 1991 Aug; 7(8):645-55. PubMed ID: 1931234
    [Abstract] [Full Text] [Related]

  • 4. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
    Lapham C, Golding B, Inman J, Blackburn R, Manischewitz J, Highet P, Golding H.
    J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
    [Abstract] [Full Text] [Related]

  • 5. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.
    Johnson RP, Hammond SA, Trocha A, Siliciano RF, Walker BD.
    J Virol; 1994 May; 68(5):3145-53. PubMed ID: 7908700
    [Abstract] [Full Text] [Related]

  • 6. Cross-reactive cytotoxic T lymphocytes induced by V3 loop synthetic peptides from different strains of human immunodeficiency virus type 1.
    Casement KS, Nehete PN, Arlinghaus RB, Sastry KJ.
    Virology; 1995 Aug 01; 211(1):261-7. PubMed ID: 7645219
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA, Bollinger RC, Stanhope PE, Quinn TC, Schwartz D, Clements ML, Siliciano RF.
    J Exp Med; 1992 Dec 01; 176(6):1531-42. PubMed ID: 1460417
    [Abstract] [Full Text] [Related]

  • 9. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance.
    Actor JK, Shirai M, Kullberg MC, Buller RM, Sher A, Berzofsky JA.
    Proc Natl Acad Sci U S A; 1993 Feb 01; 90(3):948-52. PubMed ID: 8094248
    [Abstract] [Full Text] [Related]

  • 10. Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein.
    Takahashi H, Houghten R, Putney SD, Margulies DH, Moss B, Germain RN, Berzofsky JA.
    J Exp Med; 1989 Dec 01; 170(6):2023-35. PubMed ID: 2479705
    [Abstract] [Full Text] [Related]

  • 11. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.
    Wilson SE, Pedersen SL, Kunich JC, Wilkins VL, Mann DL, Mazzara GP, Tartaglia J, Celum CL, Sheppard HW.
    AIDS Res Hum Retroviruses; 1998 Jul 20; 14(11):925-37. PubMed ID: 9686639
    [Abstract] [Full Text] [Related]

  • 12. Specific lysis of human immunodeficiency virus type 1-infected cells by a HLA-A3.1-restricted CD8+ cytotoxic T-lymphocyte clone that recognizes a conserved peptide sequence within the gp41 subunit of the envelope protein.
    Takahashi K, Dai LC, Fuerst TR, Biddison WE, Earl PL, Moss B, Ennis FA.
    Proc Natl Acad Sci U S A; 1991 Nov 15; 88(22):10277-81. PubMed ID: 1719555
    [Abstract] [Full Text] [Related]

  • 13. Cytotoxic T cell repertoire selection. A single amino acid determines alternative class I restriction.
    Bergmann CC, Tong L, Cua RV, Sensintaffar JL, Stohlman SA.
    J Immunol; 1994 Jun 15; 152(12):5603-12. PubMed ID: 7515908
    [Abstract] [Full Text] [Related]

  • 14. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L, Schirmbeck R, Reimann J, Wolf H, Wagner R.
    Virology; 1997 Aug 18; 235(1):26-39. PubMed ID: 9300034
    [Abstract] [Full Text] [Related]

  • 15. Major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins.
    McGuire TC, Tumas DB, Byrne KM, Hines MT, Leib SR, Brassfield AL, O'Rourke KI, Perryman LE.
    J Virol; 1994 Mar 18; 68(3):1459-67. PubMed ID: 8107209
    [Abstract] [Full Text] [Related]

  • 16. Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses.
    Wagner R, Böltz T, Deml L, Modrow S, Wolf H.
    J Gen Virol; 1993 Jul 18; 74 ( Pt 7)():1261-9. PubMed ID: 7687647
    [Abstract] [Full Text] [Related]

  • 17. Inactivation of human immunodeficiency virus (HIV)-1 envelope-specific CD8+ cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism?
    Takahashi H, Nakagawa Y, Leggatt GR, Ishida Y, Saito T, Yokomuro K, Berzofsky JA.
    J Exp Med; 1996 Mar 01; 183(3):879-89. PubMed ID: 8642292
    [Abstract] [Full Text] [Related]

  • 18. Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization.
    Tobery TW, Siliciano RF.
    J Exp Med; 1997 Mar 03; 185(5):909-20. PubMed ID: 9120397
    [Abstract] [Full Text] [Related]

  • 19. An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein.
    Bergmann C, Stohlmann SA, McMillan M.
    Eur J Immunol; 1993 Nov 03; 23(11):2777-81. PubMed ID: 7693478
    [Abstract] [Full Text] [Related]

  • 20. Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys.
    Voss G, Li J, Manson K, Wyand M, Sodroski J, Letvin NL.
    Virology; 1995 Apr 20; 208(2):770-5. PubMed ID: 7747449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.